Morgan Stanley’s 4D Pharma PLC LBPS Stock Holding History

Morgan Stanley’s Portfolio LBPS Stock Details LBPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,360	Closed	-$7K	–	8210
2022 Q2	$7K	Sell	4,360 -39,003	-90%	-$133K	﹤0.01%	7343
2022 Q1	$210K	Buy	43,363 +22,594	+109%	+$94.4K	﹤0.01%	5894
2021 Q4	$114K	Buy	20,769 +12,041	+138%	+$81.4K	﹤0.01%	6361
2021 Q3	$54K	Sell	8,728 -12,812	-59%	-$115K	﹤0.01%	6689
2021 Q2	$232K	Buy	21,540 +171	+0.8%	+$1.98K	﹤0.01%	5938
2021 Q1	$253K	Buy	+21,369	New	+$266K	﹤0.01%	5523

Morgan Stanley's LBPS Position: Q3 2022 in Review

Morgan Stanley sold out of 4D Pharma PLC (LBPS) in Q3 2022, closing a stake of 4,360 shares — an estimated $7K sold.

Morgan Stanley first reported a position in LBPS in Q1 2021 and held it in 6 quarters. The position peaked at $253K in Q1 2021. 1 fund tracked by Wall St. Rank holds LBPS as of Q3 2022.

Morgan Stanley reported no remaining 4D Pharma PLC position as of Q3 2022 after selling out during the quarter.
Morgan Stanley sold 4,360 4D Pharma PLC shares in Q3 2022, an estimated $7K.
Morgan Stanley first reported a position in 4D Pharma PLC in Q1 2021 and held it in 6 quarters.
Morgan Stanley's 4D Pharma PLC position peaked at $253K in Q1 2021.
1 fund tracked by Wall St. Rank held 4D Pharma PLC as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.